FRI0445 Faecal calprotectin, but not anti-saccharomyces cerevisiae antibodies, is linked to worse disease status in axial spondyloarthritis patients without inflammatory bowel disease: results from the spartakus cohort

Abstract

BackgroundInflammatory bowel disease (IBD) is a common comorbidity in axial spondyloarthritis.ObjectivesTo study faecal calprotectin (F-calprotectin) levels and anti-Saccharomyces cerevisiae antibodies (ASCA) and their associations with disease status and gastrointestinal (GI)...